• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Impact of US Midterm Elections on Bitcoin Price

chest

Analysis of Bitcoin's performance during US midterm elections and its potential impact on price.

user avatarJesper Sørensen

Bitcoin Price Recovery Amid Geopolitical Tensions

chest

Bitcoin has been on a steady recovery journey over the past few weeks, with several attempts at a sustained break above the 74,000 level, despite ongoing geopolitical tensions.

user avatarRajesh Kumar

Solana Faces Mixed Signals as Price Tightens

chest

Solana's price is showing mixed signals as it tightens beneath key resistance levels, with early signs of momentum weakness emerging.

user avatarFilippo Romano

Emerging Weakness in Solana's Structure Noted

chest

Analysts highlight emerging weakness in Solana's structure, with potential for a broader move lower if key support levels are broken.

user avatarLucas Weissmann

Ripple's Legal Victory Over SEC Confirmed by Token Taxonomy

chest

Ripple's survey comes just as the SEC released a token taxonomy that confirmed XRP is a digital commodity, not a security.

user avatarEmily Carter

Private Crypto Holders Face Significant Losses Due to New Malware

chest

Private crypto holders faced significant losses due to a new iOS malware called Ghostblade, which targets sensitive data and personal information.

user avatarTomas Novak

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.